Article
MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer
25 Nov 2022
Abstract excerpt
The telomeric repeat-binding factor 2 (TRF2) is a telomere-capping protein that plays a key role in the maintenance of telomere structure and function. It is highly expressed in different cancer types, and it contributes to cancer progression. To date, anti-cancer strategies to target TRF2 remain a challenge. Here, we developed a miRNA-based approach to reduce TRF2 expression. By performing a high-throughput...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
